Market by Display, Technology, Type, End-user, and Country Outlook | Forecast 2022-2028
Triton Market Research’s report concludes that the cardiovascular ultrasound market in North America would progress with a 5.38% CAGR in the forecast period 2022-2028.
Report scope can be customized per your requirements. Request For Customization
The countries analyzed in this region include:
• The United States
• Canada
The
United States is expected to be the fastest-growing market in this region in
the coming years. The region is home to a number
of leading companies, which largely aids in the market’s growth. The innovative
products offered by these players allow healthcare professionals to diagnose
and monitor cardiovascular health problems more effectively. On the other hand,
strict regulatory frameworks and associated guidelines are limiting the
advancement of the cardiovascular ultrasound market in North America.
It is reported that,
every 34 seconds, one person dies from cardiovascular disease (CVD) in the
United States. Every year, close to 805,000 people in the nation suffer a heart
attack. Further, it is estimated that, by 2035, 45% of Americans would be
affected by at least one heart-related disease. The growing incidence of heart
diseases presents opportunities for market players to offer innovative echocardiography
devices to aid in timely diagnosis so that patients can seek appropriate care.
In Canada, CVD affects around
2.4 million individuals, and is the second leading cause of death in the
country. 1 out of every 10 hospitalizations here is attributable to heart
disease, vascular cognitive impairment, or stroke. Multiple factors, such as an
aging population, stressful lifestyles, and poor dietary choices, are
contributing to the rising incidence of cardiovascular ailments. This growing
disease incidence necessitates the use of cardiovascular ultrasound systems for
timely detection. Increased adoption will foster the growth of the Canadian
market in the coming years.
Diagnostic centers have
trained specialists and dedicated equipment to perform numerous tests,
including ultrasound imaging. Some hospitals are not equipped with
cardiovascular ultrasound equipment in their premises. As a result, patients
are redirected to these centers to undergo tests.
The
report assesses the market based on end-user, display, technology, and type.
Here, the end-user segment comprises diagnostic centers, hospitals, ambulatory
care centers, and other end-users.
The
noteworthy companies in the cardiovascular ultrasound market include Zoncare,
Leltek Inc, Mindray Medical International Limited, Canon Medical Corp, Siemens
Healthineers, Esaote S.p.A., Viatom Technology Co, and Clarius.
Clarius is a leading medical
technology company based in Canada. It manufactures a range of scanners and
associated accessories for cardiology, critical care, vascular access,
emergency medical services, and other application areas. The PA HD3 wireless
scanner manufactured by the company offers superior cardiac imaging. With its innovation-driven
approach, Clarius has replaced complex knobs and buttons of traditional
ultrasound systems with an AI-powered app offering intuitive touch-based
controls. Established in 2014, the company is headquartered in Vancouver,
British Columbia.
Key deliverables of the report:
·
Market
CAGR during the forecasting years 2022-2028
·
Detailed
data highlighting key insights, industry components, and market strategies
·
Comprehensive
information and estimation of the cardiovascular ultrasound market revenue
growth in North America and its influence on the parent market
·
In-depth
study of forthcoming trends in consumer behavioral patterns
·
A
meticulous analysis of the competitive landscape, vendor scorecard, and
Porter’s Five Forces Analysis Model
·
A
wide-ranging study of factors that will challenge the North America cardiovascular
ultrasound market’s growth during the upcoming years
Want
to get specific insights? Our team of analysts can customize this report based
on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA CARDIOVASCULAR ULTRASOUND MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE CARDIOVASCULAR ULTRASOUND MARKET
2.2. KEY
INSIGHTS
2.2.1. EMERGENCE
OF ARTIFICIAL INTELLIGENCE (AI)
2.2.2. STRAIN
IMAGING HAS SEEN A GRADUAL INCREASE
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. DURABILITY
2.4.3. PRICE
2.4.4. TECHNOLOGY
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. PRODUCT
LAUNCHES
2.9.2. ALLIANCES
2.10. MARKET
DRIVERS
2.10.1. INCREASE
IN CARDIOVASCULAR DISEASE CASES
2.10.2. ADVANCEMENTS
IN TECHNOLOGY
2.11. MARKET
CHALLENGES
2.11.1. LACK
OF AWARENESS AMONG PATIENTS
2.11.2. NEED
TO ABIDE BY STRINGENT REGULATIONS
2.12. MARKET
OPPORTUNITIES
2.12.1. RAPID
EXPANSION OF POINT-OF-CARE ULTRASOUND (POCUS)
2.12.2. RAPID
GROWTH OF FETAL ECHOCARDIOGRAPHY
3. NORTH
AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY DISPLAY
3.1. BLACK
AND WHITE
3.2. COLORED
4. NORTH
AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TECHNOLOGY
4.1. 2D
4.2. 3D/4D
4.3. DOPPLER
5. NORTH
AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TYPE
5.1. TRANSTHORACIC
ECHOCARDIOGRAPHY
5.2. FETAL
ECHOCARDIOGRAPHY
5.3. TRANSESOPHAGEAL
ECHOCARDIOGRAPHY
5.4. OTHER
TYPES
6. NORTH
AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS
6.2. DIAGNOSTIC
CENTERS
6.3. AMBULATORY
CARE CENTERS
6.4. OTHER
END-USERS
7. NORTH
AMERICA CARDIOVASCULAR ULTRASOUND MARKET – COUNTRY OUTLOOK
7.1. UNITED
STATES
7.2. CANADA
8. COMPETITIVE
LANDSCAPE
8.1. GE
HEALTHCARE
8.2. PHILIPS
HEALTHCARE
8.3. SIEMENS
HEALTHINEERS
8.4. CANON
MEDICAL CORP
8.5. FUJIFILM
HOLDINGS CORPORATION
8.6. SAMSUNG
MEDISON CO LTD
8.7. ESAOTE
S.P.A.
8.8. MINDRAY
MEDICAL INTERNATIONAL LIMITED
8.9. VIATOM
TECHNOLOGY CO
8.10. LANMAGE
8.11. DAWEI
MEDICAL
8.12. ZONCARE
8.13. LELTEK
INC
8.14. TELEMED
ULTRASOUND MEDICAL SYSTEMS
8.15. CLARIUS
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA CARDIOVASCULAR
ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: LIST OF ALLIANCES
TABLE 6: NORTH AMERICA
CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA
CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA
CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA CARDIOVASCULAR
ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA
CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
FIGURE
1: KEY BUYING IMPACT ANALYSIS
FIGURE
2: MARKET ATTRACTIVENESS INDEX
FIGURE
3: INDUSTRY COMPONENTS
FIGURE
4: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2021 & 2028
(IN %)
FIGURE
5: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE,
2022-2028 (IN $ MILLION)
FIGURE
6: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY COLORED, 2022-2028 (IN $
MILLION)
FIGURE
7: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2021 &
2028 (IN %)
FIGURE
8: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2028 (IN $
MILLION)
FIGURE
9: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2028 (IN $
MILLION)
FIGURE
10: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DOPPLER, 2022-2028 (IN $
MILLION)
FIGURE
11: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2021 & 2028
(IN %)
FIGURE
12: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC
ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE
13: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY,
2022-2028 (IN $ MILLION)
FIGURE
14: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL
ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE
15: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2028
(IN $ MILLION)
FIGURE
16: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2021 &
2028 (IN %)
FIGURE
17: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2028 (IN
$ MILLION)
FIGURE
18: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS,
2022-2028 (IN $ MILLION)
FIGURE
19: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS,
2022-2028 (IN $ MILLION)
FIGURE
20: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS,
2022-2028 (IN $ MILLION)
FIGURE
21: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 &
2028 (IN %)
FIGURE
22: UNITED STATES CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE
23: CANADA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)